Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
26.00
+7.50 (40.54%)
At close: Nov 13, 2025
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
$482,221
Profits / Employee
$20,495
Market Cap
30.85B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
| Dec 31, 2022 | 35,125 | -854 | -2.37% |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Zomedica | 152 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
Teva Pharmaceutical Industries News
- 3 days ago - Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva® - GlobeNewsWire
- 7 days ago - Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December - GlobeNewsWire
- 9 days ago - Teva seeks startups to help solve global pharmaceutical challenges - Reuters
- 10 days ago - Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Gleview Capital Adjusts Portfolio, Increases Stake in Teva Pharmaceutical (TEVA) - GuruFocus
- 14 days ago - Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business - Seeking Alpha
- 17 days ago - Insider Selling: Amir Weiss Unloads $300K Of Teva Pharmaceutical Indus Stock - Benzinga
- 18 days ago - Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023 - The Motley Fool